SGIOF
Price
$16.79
Change
+$0.24 (+1.45%)
Updated
Jul 30 closing price
Capitalization
15.19B
TEVJF
Price
$14.32
Change
-$3.48 (-19.55%)
Updated
Aug 8 closing price
Capitalization
20.08B
Interact to see
Advertisement

SGIOF vs TEVJF

Header iconSGIOF vs TEVJF Comparison
Open Charts SGIOF vs TEVJFBanner chart's image
Shionogi & Co
Price$16.79
Change+$0.24 (+1.45%)
Volume$435
Capitalization15.19B
Teva Pharmaceutical Industries
Price$14.32
Change-$3.48 (-19.55%)
Volume$110
Capitalization20.08B
SGIOF vs TEVJF Comparison Chart in %
Loading...
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SGIOF vs. TEVJF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGIOF is a StrongBuy and TEVJF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (SGIOF: $19.00 vs. TEVJF: $14.32)
Brand notoriety: SGIOF and TEVJF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: SGIOF: 12% vs. TEVJF: 109%
Market capitalization -- SGIOF: $15.19B vs. TEVJF: $20.08B
SGIOF [@Pharmaceuticals: Generic] is valued at $15.19B. TEVJF’s [@Pharmaceuticals: Generic] market capitalization is $20.08B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SGIOF’s FA Score shows that 2 FA rating(s) are green whileTEVJF’s FA Score has 1 green FA rating(s).

  • SGIOF’s FA Score: 2 green, 3 red.
  • TEVJF’s FA Score: 1 green, 4 red.
According to our system of comparison, SGIOF is a better buy in the long-term than TEVJF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SGIOF’s TA Score shows that 7 TA indicator(s) are bullish while TEVJF’s TA Score has 2 bullish TA indicator(s).

  • SGIOF’s TA Score: 7 bullish, 1 bearish.
  • TEVJF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, SGIOF is a better buy in the short-term than TEVJF.

Price Growth

SGIOF (@Pharmaceuticals: Generic) experienced а +13.16% price change this week, while TEVJF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVJF($20.1B) has a higher market cap than SGIOF($15.2B). SGIOF YTD gains are higher at: 55.610 vs. TEVJF (-22.595). SGIOF has higher annual earnings (EBITDA): 206B vs. TEVJF (1.9B). SGIOF has more cash in the bank: 576B vs. TEVJF (2.16B). SGIOF has less debt than TEVJF: SGIOF (11.7B) vs TEVJF (17.5B). SGIOF has higher revenues than TEVJF: SGIOF (419B) vs TEVJF (16.6B).
SGIOFTEVJFSGIOF / TEVJF
Capitalization15.2B20.1B76%
EBITDA206B1.9B10,848%
Gain YTD55.610-22.595-246%
P/E Ratio13.96N/A-
Revenue419B16.6B2,524%
Total Cash576B2.16B26,654%
Total Debt11.7B17.5B67%
FUNDAMENTALS RATINGS
SGIOF vs TEVJF: Fundamental Ratings
SGIOF
TEVJF
OUTLOOK RATING
1..100
2297
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
290
PRICE GROWTH RATING
1..100
4884
P/E GROWTH RATING
1..100
4213
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGIOF's Valuation (19) in the null industry is somewhat better than the same rating for TEVJF (73). This means that SGIOF’s stock grew somewhat faster than TEVJF’s over the last 12 months.

TEVJF's Profit vs Risk Rating (88) in the null industry is in the same range as SGIOF (100). This means that TEVJF’s stock grew similarly to SGIOF’s over the last 12 months.

SGIOF's SMR Rating (2) in the null industry is significantly better than the same rating for TEVJF (90). This means that SGIOF’s stock grew significantly faster than TEVJF’s over the last 12 months.

SGIOF's Price Growth Rating (48) in the null industry is somewhat better than the same rating for TEVJF (84). This means that SGIOF’s stock grew somewhat faster than TEVJF’s over the last 12 months.

TEVJF's P/E Growth Rating (13) in the null industry is in the same range as SGIOF (42). This means that TEVJF’s stock grew similarly to SGIOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SGIOFTEVJF
RSI
ODDS (%)
Bullish Trend 2 days ago
46%
Bullish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
49%
Bearish Trend 1 day ago
61%
MACD
ODDS (%)
Bullish Trend 2 days ago
48%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 1 day ago
44%
Advances
ODDS (%)
Bullish Trend 19 days ago
58%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
43%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SGIOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ISWN20.960.05
+0.26%
Amplify BlackSwan ISWN ETF
FLHY24.26N/A
+0.02%
Franklin High Yield Corporate ETF
RSPM32.88-0.07
-0.21%
Invesco S&P 500® Equal Weight Matrls ETF
ONEQ85.13-0.27
-0.32%
Fidelity Nasdaq Composite ETF
BKDV27.06-0.11
-0.40%
BNY Mellon Dynamic Value ETF

SGIOF and

Correlation & Price change

A.I.dvisor tells us that SGIOF and AGYTF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGIOF and AGYTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOF
1D Price
Change %
SGIOF100%
+13.16%
AGYTF - SGIOF
25%
Poorly correlated
N/A
HLNCF - SGIOF
21%
Poorly correlated
+2.77%
SFOSF - SGIOF
11%
Poorly correlated
N/A
ROMJF - SGIOF
8%
Poorly correlated
-2.03%
TEVJF - SGIOF
8%
Poorly correlated
N/A
More